ERGO (fights fat, diabetes II, and Heart disease)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ERGO (fights fat, diabetes II, and Heart disease)

An SI Board Since July 1997

Posts	SubjectMarks	Bans	Symbol
110	3	0	ERGO

Emcee: jim detwiler	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
10	From what I've read, a marketing agreement could come around Sept/Oct or th	Will Cunningham	-	7/27/1997
9	Jim, is a marketing agreement likely at anytime, or is FDA approval a prerequis	mfr	-	7/27/1997
8	ERGO: I am glad that a forum for Ergo Sciences has been started, I was sincerel	Will Cunningham	-	7/27/1997
7	Many trials including diabets and fat reduction have been completed read the re	jim detwiler	-	7/25/1997
6	Thanks Richard, sounds pretty interesting, altho I have trouble believing that	Andrew H	-	7/25/1997
5	The following is reposted from another message board posted November 4, 1996:	Richard Singer	-	7/25/1997
4	Hey, Jim, your posts sound as though they were taken verbatin from an analyst&#	Andrew H	-	7/25/1997
3	An Emerging Player in the Diabetes Field Based on a strong body of Phase III cl	jim detwiler	-	7/24/1997
2	_ First, ERGO's approach to treating diabetes and obesity represents a new	jim detwiler	-	7/23/1997
1	Jim, what specific clinical/pharmacologic advantages does Ergoset provide over	Rudy Saucillo	-	7/23/1997

Go to reply# or date (mm/dd/yy):